Increased PTH and 1.25(OH)2D Levels Associated With Increased Markers of Bone Turnover Following Bariatric Surgery
Authors:
Open Access
Abstract
The objective of this study was to characterize changes in metabolic bone parameters following bariatric surgery. Seventy‐three obese adult patients who underwent either gastric banding (GB), Roux‐en‐Y gastric bypass (RYGB), or biliopancreatic diversion with duodenal switch (BPD/DS) were followed prospectively for 18 months postoperatively. Changes in the calcium‐vitamin D axis (25‐hydroxyvitamin D (25OHD), 1,25‐dihydroxyvitamin D (1,25(OH)2D), calcium, parathyroid hormone (PTH)), markers of bone formation (osteocalcin, bone‐specific alkaline phosphatase) and resorption (urinary N‐telopeptide (NTx)), as well as bone mineral density (BMD) were assessed at 3‐month intervals during this time period. Bariatric surgery resulted in significant and progressive weight loss over 18 months. With supplementation, 25OHD levels increased 65.3% (P < 0.0001) by 3 months, but leveled off and decreased P = 0.01) at 3 months, but later approached presurgery levels. 1,25(OH)2D increased significantly starting at month 12 (50.3% increase from baseline, P = 0.008), and was positively associated with PTH (r = 0.82, P = 0.0001). When stratified by surgery type, median PTH and 1,25(OH)2D levels were higher following combined restrictive and malabsorptive operations (RYGB and BPD/DS) compared to GB. Bone formation/resorption markers were increased by 3 months (P < 0.05) and remained elevated through 18 months. Radial BMD decreased 3.5% by month 18, but this change was not significant (P = 0.23). Our findings show that after transient improvement, preoperative vitamin D insufficiency and secondary hyperparathyroidism persisted following surgery despite supplementation. Postoperative secondary hyperparathyroidism was associated with increased 1,25(OH)2D levels and increased bone turnover markers.Keywords
This publication has 27 references indexed in Scilit:
- Back to the Future: Revisiting Parathyroid Hormone and Calcitonin Control of Bone RemodelingHormone and Metabolic Research, 2010
- Serum Markers of Bone Turnover Are Increased at Six and 18 Months after Roux-En-Y Bariatric Surgery: Correlation with the Reduction in LeptinThe Journal of Clinical Endocrinology & Metabolism, 2010
- Metabolic/Bariatric Surgery Worldwide 2008Obesity Surgery, 2009
- Increase of Bone Resorption and the Parathyroid Hormone in Postmenopausal Women in the Long-term after Roux-en-Y Gastric BypassObesity Surgery, 2009
- Incidence of bone loss, falls, and fractures after Roux-en-Y gastric bypass for morbid obesityApplied Nursing Research, 2009
- The Decline in Hip Bone Density after Gastric Bypass Surgery Is Associated with Extent of Weight LossThe Journal of Clinical Endocrinology & Metabolism, 2008
- ASMBS Allied Health Nutritional Guidelines for the Surgical Weight Loss PatientSurgery for Obesity and Related Diseases, 2008
- Surgery Decreases Long-term Mortality, Morbidity, and Health Care Use in Morbidly Obese PatientsAnnals of Surgery, 2004
- Bone metabolism and risk of secondary hyperparathyroidism 12 months after gastric banding in obese pre-menopausal womenInternational Journal of Obesity, 2003
- American Heart Association Call to Action: Obesity as a Major Risk Factor for Coronary Heart DiseaseCirculation, 1998